Is Biofrontera Warrants Stock a Good Investment?
Biofrontera Warrants Investment Advice | BFRIW |
Not Rated
Examine Biofrontera Warrants Stock
Researching Biofrontera Warrants' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 1.3. Biofrontera Warrants had not issued any dividends in recent years.
To determine if Biofrontera Warrants is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Biofrontera Warrants' research are outlined below:
| Biofrontera Warrants is not yet fully synchronised with the market data | |
| Biofrontera Warrants is way too risky over 90 days horizon | |
| Biofrontera Warrants has some characteristics of a very speculative penny stock | |
| Biofrontera Warrants appears to be risky and price may revert if volatility continues | |
| Biofrontera Warrants has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 37.32 M. Net Loss for the year was (17.76 M) with profit before overhead, payroll, taxes, and interest of 16.66 M. | |
| Biofrontera Warrants generates negative cash flow from operations | |
| Latest headline from gurufocus.com: Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update |
Biofrontera Warrants' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.80) | (0.85) | |
| Return On Capital Employed | (1.71) | (1.79) | |
| Return On Assets | (0.80) | (0.84) | |
| Return On Equity | (4.01) | (4.21) |
Determining Biofrontera Warrants' profitability involves analyzing its financial statements and using various financial metrics to determine if Biofrontera Warrants is a good buy. For example, gross profit margin measures Biofrontera Warrants' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Biofrontera Warrants' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Biofrontera Warrants' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biofrontera Warrants. Check Biofrontera Warrants' Beneish M Score to see the likelihood of Biofrontera Warrants' management manipulating its earnings.
Evaluate Biofrontera Warrants' management efficiency
The company has return on total asset (ROA) of (0.46) % which means that it has lost $0.46 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.9089) %, meaning that it generated substantial loss on money invested by shareholders. Biofrontera Warrants' management efficiency ratios could be used to measure how well Biofrontera Warrants manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.85 in 2025. Return On Capital Employed is likely to drop to -1.79 in 2025. At this time, Biofrontera Warrants' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 23.5 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 363.9 K in 2025.| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (349.32) | (331.86) | |
| Price Book Value Ratio | 1.4 K | 1.4 K | |
| Enterprise Value Multiple | (349.32) | (331.86) | |
| Price Fair Value | 1.4 K | 1.4 K | |
| Enterprise Value | 9.6 M | 9.1 M |
The operational strategies employed by Biofrontera Warrants management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta 0.313 |
Biofrontera Warrants' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biofrontera Warrants insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biofrontera Warrants' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biofrontera Warrants insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hermann Luebbert over two weeks ago Disposition of 95420 shares by Hermann Luebbert of Biofrontera Warrants subject to Rule 16b-3 | ||
Lanckriet Heikki over three months ago Insider Trading |
Understand Biofrontera Warrants' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Biofrontera Warrants' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1216 | |||
| Market Risk Adjusted Performance | 0.6137 | |||
| Mean Deviation | 17.92 | |||
| Semi Deviation | 17.35 | |||
| Downside Deviation | 21.9 | |||
| Coefficient Of Variation | 806.4 | |||
| Standard Deviation | 26.81 | |||
| Variance | 718.86 | |||
| Information Ratio | 0.125 | |||
| Jensen Alpha | 3.52 | |||
| Total Risk Alpha | 4.4 | |||
| Sortino Ratio | 0.153 | |||
| Treynor Ratio | 0.6037 | |||
| Maximum Drawdown | 138.66 | |||
| Value At Risk | (35.22) | |||
| Potential Upside | 64.77 | |||
| Downside Variance | 479.62 | |||
| Semi Variance | 300.88 | |||
| Expected Short fall | (22.54) | |||
| Skewness | 1.37 | |||
| Kurtosis | 3.39 |
| Risk Adjusted Performance | 0.1216 | |||
| Market Risk Adjusted Performance | 0.6137 | |||
| Mean Deviation | 17.92 | |||
| Semi Deviation | 17.35 | |||
| Downside Deviation | 21.9 | |||
| Coefficient Of Variation | 806.4 | |||
| Standard Deviation | 26.81 | |||
| Variance | 718.86 | |||
| Information Ratio | 0.125 | |||
| Jensen Alpha | 3.52 | |||
| Total Risk Alpha | 4.4 | |||
| Sortino Ratio | 0.153 | |||
| Treynor Ratio | 0.6037 | |||
| Maximum Drawdown | 138.66 | |||
| Value At Risk | (35.22) | |||
| Potential Upside | 64.77 | |||
| Downside Variance | 479.62 | |||
| Semi Variance | 300.88 | |||
| Expected Short fall | (22.54) | |||
| Skewness | 1.37 | |||
| Kurtosis | 3.39 |
Consider Biofrontera Warrants' intraday indicators
Biofrontera Warrants intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biofrontera Warrants stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.34 | |||
| Daily Balance Of Power | 0.7232 | |||
| Rate Of Daily Change | 1.35 | |||
| Day Median Price | 0.0815 | |||
| Day Typical Price | 0.0858 | |||
| Market Facilitation Index | 0.0336 | |||
| Price Action Indicator | 0.0249 | |||
| Period Momentum Indicator | 0.0243 | |||
| Relative Strength Index | 55.81 |
Biofrontera Stock media impact
Far too much social signal, news, headlines, and media speculation about Biofrontera Warrants that are available to investors today. That information is available publicly through Biofrontera media outlets and privately through word of mouth or via Biofrontera internal channels. However, regardless of the origin, that massive amount of Biofrontera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biofrontera Warrants news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biofrontera Warrants relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biofrontera Warrants' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biofrontera Warrants alpha.
Biofrontera Warrants Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Biofrontera Warrants can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Biofrontera Warrants Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biofrontera Warrants stock to make a market-neutral strategy. Peer analysis of Biofrontera Warrants could also be used in its relative valuation, which is a method of valuing Biofrontera Warrants by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biofrontera Warrants Corporate Management
| Jon MBA | Vice Affairs | Profile | |
| Daniel JD | General Compliance | Profile | |
| Mark Baldyga | Vice Marketing | Profile | |
| Alycia Torres | Vice Administration | Profile | |
| Samantha Widdicombe | Senior Communications | Profile | |
| Eugene III | Chief Officer | Profile |
Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.